Glaxosmithkline Pharmaceuticals informs about disclosure

11 Feb 2025 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the Company has received an Order dated 4th February 2025 for the period July 2017 to March 2018 from Additional Commissioner Adjudication, Delhi-North, raising a demand of Rs 2,19,72,072 in Delhi State. The relevant details to be is disclosed is as enclosed.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2856.05 52.00 (1.85%)
28-Apr-2025 14:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1832.25
Dr. Reddys Lab 1194.20
Cipla 1556.50
Lupin 2101.05
Zydus Lifesciences 884.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...